Blavatnik Biomedical Accelerator at Harvard University

Therapeutic Approaches: Biologics, Small Molecules, Vaccines, Biomarkers, Antibodies, Stem Cells, Gene Therapy, Drug Delivery, Drug Devices, Diagnostic and analytical methods, biomaterials

Therapeutic Areas of Expertise: Cardiology, Gene-Therapy, Immunology, Infectious Diseases, Metabolic Disorders, Neurological Disorders, Oncology, Ophthalmology, Psychiatric Disorders, Pain, Regenerative Medicine

Center/Program Highlights:

Biomedical research at Harvard has the potential to improve countless lives, revolutionize industries, and create immense social and economic value. Translating this early-stage research into compelling, validated technologies requires careful planning, focused resources, and a tireless pursuit of results.

The Blavatnik Biomedical Accelerator guides Harvard scientists toward translational impact by providing strategic, monetary, and advisory support for well-defined research projects. Our work is expressly aimed at hastening the pace of scientific progress, developing a shared vision with partners in industry, and ensuring that lifesaving technologies born at Harvard will become new products that impact the world for the better.


The Accelerator seeks to support innovative, investigator-initiated research, and to develop preliminary observations into robust intellectual property positions. Its primary goal is to advance technologies to the point where an industry partnership can commence.

We employ a proven strategy of selecting projects with significant commercial potential, and providing financial support and domain expertise to fuel translational research, proof-of-concept, and technological development. We simultaneously build relationships with industry, generating partnerships and licensing opportunities, and facilitating startup formation and investment.

Sources of Funding: Philanthropy, Revenue


Institutional Affiliation(s): Harvard University

Smith 639, 1350 Massachusetts Avenue
Massachusetts, 02138
United States

Center/Program Start Date: 2007

Number of Employees: 3